Dermatology Reports (Aug 2024)

Blue diode laser as supportive therapy for the management of vulvar lichen sclerosus

  • Serena Bergamo,
  • Margherita Gobbo,
  • Silvia Chimenton,
  • Giorgia D'Angelo,
  • Luca Guarda Nardini,
  • Alessandro Gatti

DOI
https://doi.org/10.4081/dr.2024.10046

Abstract

Read online

Vulvar lichen sclerosus is a chronic inflammatory condition characterized by the thinning and atrophy of the skin and mucosa surrounding the vulva and anus. This study evaluates the efficacy of a treatment protocol utilizing blue-diode laser photobiomodulation in managing vulval lichen sclerosus symptoms in a cohort of 12 female patients. The treatment protocol consisted of laser sessions for 3 times a week for 2 weeks, and follow-up sessions over a 16-week period. Objective and subjective parameters were assessed before treatment, at the end of treatment, and at 4-month follow-up visits. Results demonstrated significant reductions in subjective symptoms such as itching and pain, as well as improvements in objective signs including erythema and fissures. No side effects were observed, indicating the safety and tolerability of laser treatment. These findings suggest that photobiomodulation can be an effective therapeutic option for patients with vulval lichen sclerosus, with future research aimed at refining treatment protocols and evaluating its long-term benefits.

Keywords